Trial intelligence / Profile preview

Intravenous ibuprofen for pain management in morbidly obese patients undergoing elective surgery

PACTR202606479059924Phase 4Completed

Sponsor
Kafrelsheikh University Hospital
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of ibuprofen in postoperative pain, sponsored by Kafrelsheikh University Hospital. Primary endpoint: Analgesic efficacy and recovery characteristics. Started Nov 2024; status: completed.

02

Drugs

ibuprofen
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202606479059924.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202606479059924.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call